Pharmacist-Led SDoH Screening Intervention During Transitions of Care in an Acute Care Setting

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

July 15, 2025

Study Completion Date

September 15, 2025

Conditions
Health Related Social Needs (HRSN)PharmacyMedication Reconciliation
Interventions
OTHER

Intervention

The intervention incorporates a multifaceted pharmacist-led approach to addressing health-related social needs (HRSN) during transitions of care in the emergency department (ED) at Buffalo General Medical Center (BGMC). The intervention includes: 1) pharmacist-led medication reconciliation, and 2) HRSN screening using the Accountable Health Communities (AHC) HRSN tool. Based on the results, patients receive tailored referrals to community-based organizations using the 211 WNY database, which provides localized resources aligned with their social needs. Each patient is given a printed handout detailing the referral information. Within one month, a follow-up phone call is conducted to follow up with patients and assess additional needs as well as collect feedback through a patient satisfaction survey.

OTHER

Control

The control arm of the study consists of a historical cohort of patients who were admitted to or discharged from the emergency department (ED) at Buffalo General Medical Center (BGMC) during the same timeframe as the intervention arm but did not receive the pharmacist-led health-related social needs (HRSN) screening or referral intervention. These patients are identified through the electronic health record (EHR) based on the same inclusion criteria as the intervention group, such as age, geographic location, and discharge disposition. Control participants are matched 1:1 with intervention participants using demographic and clinical characteristics, including age (within 5 years), zip code, insurance type, discharge status, and race. Data for the control arm include healthcare utilization metrics such as 30- and 90-day unplanned hospital readmissions and emergency department visits. The control arm serves as a comparator to evaluate the effectiveness of the intervention

Trial Locations (1)

14203

Buffalo General Medical Center, Buffalo

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

State University of New York at Buffalo

OTHER

NCT06802393 - Pharmacist-Led SDoH Screening Intervention During Transitions of Care in an Acute Care Setting | Biotech Hunter | Biotech Hunter